E-drug: Re: Phenlybutazone availability - thank you
-------------------------------------------------------------------------
Dear Colleagues,
I wish to thank you all for the quick response you gave on the availability
of phenylbutazone.
Your responses will go a long way in assisting us in making a decision
whether to
reintroduce this product in the market or not.
I will communicate the decision made.
Kind Regards.
Bibiana Njue.
HEAD DRUG REGISTRATION
PHARMACY&POISONS BOARD KENYA
P.O BOX 30016 NAIROBI
FAX 254-2-712495
kndpbn@net2000ke.com
[Note from the moderator: The decision, I hope, will be not to reintroduce
it! KM]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.